The quest for well-being: A qualitative study of the experience of taking antipsychotic medication

被引:60
作者
Carrick, R
Mitchell, A
Powell, RA
Lloyd, K
机构
[1] Peninsula Med Sch, Mental Hlth Res Grp, Exeter EX2 5AF, Devon, England
[2] Univ Exeter, Dept Mental Hlth, Exeter, Devon, England
[3] Univ Exeter, Sch Psychol, Exeter, Devon, England
关键词
D O I
10.1348/147608304322874236
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Antipsychotic medication is integral to the treatment of severe and enduring mental health problems (e.g. schizophrenia). Such medication is associated with significant adverse side effects that can affect treatment adherence. To date there have been few attempts to analyse qualitatively service users' experience of taking antipsychotic medication. This study, conducted in Exeter, South West England, investigates the subjective experience of side effects of antipsychotic medication to gain a greater understanding of service users' experiences and to gain insights into adherence issues. Data were analysed using a variant of grounded theory (Glaser & Strauss, 1967) and a model of the experience of taking antipsychotic medication was constructed. The interview schedule was then refined and further interviews (including a focus group) were conducted among a diverse sample recruited from local day centres. Results indicated that people taking antipsychotic medication do not see side effects and symptoms as separate issues. Instead, they describe drugs as 'good' or 'terrible'-an indication of the total impact of their treatment. The model constructed reflects this, having the core concept of Well-being: that is, normality of function, feeling and appearance to the outside world. Major themes relating to this core category were managing treatment, evaluating treatment and understanding of the situation. Implications for medication adherence and clinical practice, including drug choice, are discussed, and the doctor-patient relationship is also considered.
引用
收藏
页码:19 / 33
页数:15
相关论文
共 44 条
[1]  
[Anonymous], OUR HLTH NAT CONTR H
[2]  
[Anonymous], BASICS QUALITATIVE R
[3]   Assessment of the patient's subjective experience in acute neuroleptic treatment: Implications for compliance and outcome [J].
Awad, AG ;
Voruganti, LNP ;
Heslegrave, RJ ;
Hogan, TP .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1996, 11 :55-59
[4]   How to distinguish between the neuroleptic-induced deficit syndrome, depression and disease-related negative symptoms in schizophrenia [J].
Barnes, TRE ;
McPhillips, MA .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1995, 10 :115-121
[5]  
Barney G., 1967, Awareness of Dying, DOI DOI 10.4324/9780203793206
[6]   Patients' unvoiced agendas in general practice consultations: qualitative study [J].
Barry, CA ;
Bradley, CP ;
Britten, N ;
Stevenson, FA ;
Barber, N .
BRITISH MEDICAL JOURNAL, 2000, 320 (7244) :1246-1250
[7]   Antipsychotic agents: A survey of the prevalence, severity and burden of side effects [J].
Bhavnani, SM ;
Levin, GM .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1996, 11 (01) :1-12
[8]  
BRENNER M, 1985, RES INTEVIEW
[9]   Misunderstandings in prescribing decisions in general practice: qualitative study [J].
Britten, N ;
Stevenson, FA ;
Barry, CA ;
Barber, N ;
Bradley, CP .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7233) :484-488
[10]   Excess mortality of schizophrenia - A meta-analysis [J].
Brown, S .
BRITISH JOURNAL OF PSYCHIATRY, 1997, 171 :502-508